Hematologic Malignancy
Chronic Phase Primary Myelofibrosis
CI-CAN-00007481Explore in graph →
Hematologic
- NCIt
- C188314
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00007481Explore in graph →
Clinical trials
2 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02440685 | A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors | terminated | Phase 1 / Phase 2 | 51 | Asana BioSciencesINDUSTRY | 2 | Jun 7, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Jun 7, 2023source: clinicaltrials